U.S. Attorney for the District of Massachusetts: Drugmaker Nostrum and CEO Agree to Pay Up to $50M to Resolve Claims of Underpaying Rebates Owed Under Medicaid Drug Rebate Program
October 31, 2023
October 31, 2023
BOSTON, Massachusetts, Oct. 31 -- The office of the U.S. Attorney for the District of Massachusetts issued the following news release:
Nostrum Laboratories, Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,825,000 and up to $50 million if certain financial contingencies are met, to resolve allegations that they violated the False Claims Act by knowingly underpaying Medicaid rebates due for Nos . . .
Nostrum Laboratories, Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,825,000 and up to $50 million if certain financial contingencies are met, to resolve allegations that they violated the False Claims Act by knowingly underpaying Medicaid rebates due for Nos . . .